Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-58,300
Closed -$4.41M 1777
2026
Q1
$4.41M Sell
58,300
-212,500
-78% -$16M 0.04% 482
2025
Q4
$20.2M Buy
+270,800
New +$19.8M 0.16% 103

Other funds holding HOLX

Michael Gelband's HOLX Position: Q2 2026 in Review

Michael Gelband sold out of Hologic (HOLX) in Q2 2026, closing a stake of 187,082 shares — an estimated $14.1M sold.

Michael Gelband first reported a position in HOLX in Q2 2019 and held it in 21 quarters. The position peaked at $35.4M in Q2 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Michael Gelband reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Michael Gelband sold 187,082 Hologic shares in Q2 2026, an estimated $14.1M.
  • Michael Gelband first reported a position in Hologic in Q2 2019 and held it in 21 quarters.
  • Michael Gelband's Hologic position peaked at $35.4M in Q2 2025.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.